A STUDY OF ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY OF THE LEAVES OF COLOCASIA ESCULENTA LINN.
HTML Full TextA STUDY OF ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY OF THE LEAVES OF COLOCASIA ESCULENTA LINN.
Sarmistha Dutta * and Biswajit Aich
Department of Pharmacology, Gauhati Medical College and Hospital, Guwahati -781032, Assam, India.
ABSTRACT: Aim: The study was done to evaluate the antibacterial and antifungal activity of the leaves of Colocasia esculenta Linn. Materials and Methods: Fresh tender leaves of C.esculenta collected, air-dried at room temperature, grounded to a fine powder and extracted with ethanol. The antibacterial and antifungal activity of C.esculenta compared to standard antibiotics was assessed by disc diffusion method by measuring the zone of inhibition. The organisms used for the test were Staphylococcus aureus, Klebsiella, Escherichia coli and Pseudomonas aeruginosa and Candida albicans. The agar disc diffusion method described by Kirby-Bauer was used for testing the antibacterial and antifungal activity. Results: Zone of inhibitions produced by sensitive organisms were demarcated by a circular area of clearing around plant extract impregnated discs and measured in millimeter (mm). Mean ± SEM was calculated and the data was statistically analysed by one way ANOVA followed by Dunnets multiple comparison test. Conclusion: In our study, ethanolic extract of Colocasia esculenta showed antibacterial activity against S. aureus, P. aeruginosa, E.coli, Kleibsiella and antifungal activity against C. albicans in a dose dependant manner.
Keywords: |
Antibacterial, Antifungal, Colocasia esculenta, Zone of inhibition, Agar diffusion
INTRODUCTION: Anti-microbial agents are undeniably one of the most important therapeutic discoveries of the 20th century 1. Widespread and indiscriminate use of antibacterial agents resulted in development of drug resistance among many virulent pathogenic bacteria 2. The clinical efficacy of many existing antibiotics is being threatened by rapid emergence of multidrug-resistant pathogens. Many infectious diseases have been known to be treated with herbal remedies throughout the history of mankind 3. Colocasia esculenta is herbaceous perennial plant belonging to the Araceae family 4.
They have a large corm on or just below the ground surface. The leaves are large to very large, 20–150 cm (7.9–59.1 in) long, with a sagittate shape. The “elephant's-ear” plant gets its name from the leaves, which are shaped like a large ear or shield. Both the roots and leaves are edible parts of the plant 5. Originating in Asia, C.esculenta also known as ‘Taro’ is now primarily found in tropical and subtropical regions 6. It is also known as Arum esculentum L. and Colocasia antiquorum Schott.7. It is commonly called as taro (English); alavi, patarveliya (Gujarati); arvi, kachalu (Hindi); alu (Marathi); alupam, alukam (Sanskrit); and sempu (Tamil), kosu (Assamese) 8, 9. Fresh edible leaves of Colocasia esculenta form rich source of protein, ascorbic acid, dietary fibre 10 and some nutritionally important minerals and vitamins such as calcium, phosphorous, iron, Vitamin C, thiamine, riboflavin and niacin 6. In its raw form, the plant is toxic due to the presence of calcium oxalate and the presence of needle shaped raphides in the plant cells 5.
Scientific classification:
Kingdom: Plantae
Order: Alismatales
Family: Araceae
Subfamily: Aroideae
Tribe: Colocasiodeae
Genus: Colocasia
Species: Colocasia esculenta 5
The herb has been known since ancient times for its curative properties and has been utilized for treatment of various ailments such as asthma, arthritis, diarrhea, internal hemorrhage, neurological disorders, and skin disorders 6. Whole plant is crushed into paste and applied on insect stings, cuts, burns and internal hemorrhage 11. The study was done to evaluate the antibacterial and antifungal activity of the leaves of Colocasia esculenta Linn.
MATERIALS AND METHODS:
Collection, Identification and Extraction of Plant:
Materials: Approximately 1 kg of fresh tender leaves of C.esculenta collected during July-August 2014 was used for the study. The plant material was air-dried at room temperature. The dried leaves were grounded to a fine powder and stored in an air tight container.
Preparation of the Extract: Two hundred and fifty grams of the dry powder obtained was subjected to continuous Soxhlet extraction. The extract was collected in Petri dishes 12. The extract was concentrated in vacuum using a rotary flash evaporator. There was a net yield of 22.6 g of the concentrated extract (9.12%). The extract was stored in a refrigerator at 4°C in labeled air-tight containers for further use. The dried extracts were dissolved in dimethyl sulphoxide (DMSO) and subjected to antibacterial activity.
Drugs and chemicals used in the study:
- Ethanolic extract of leaves of esculenta (EECE)
- Antibiotic discs obtained from Ranbaxy Pharmaceuticals.
- Petridises
- Agar obtained from Himedia Laboratories, Mumbai.
The present study was conducted in the Department of Pharmacology and Department of Microbiology, Gauhati Medical College, Guwahati after getting approval from Institutional Ethics Committee (No.MC/233/2013/264).
Evaluation of Antibacterial and Antifungal Activity:
Test organisms: The organisms used for the test were Staphylococcus aureus (S. Aureus), Klebsiella sp, Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa) and Candida albicans (C.albicans). The stock cultures were obtained from Department of Microbiology, Gauhati Medical College, Guwahati, Assam, India.
Preparation of plant extract impregnated discs: Whatman filter paper no.1 was used to prepare discs of 5mm. Sterilization was done by autoclaving and subsequently dried at 80ºC for an hour in hot air oven. Then the discs were impregnated with ethanolic extracts of C.esculenta. Each produced disc have the ability to absorb about 0.01ml.
Testing method for Antibacterial and Antifungal activity: The modified agar disc diffusion method originally described in 1966 by Kirby-Bauer 13 was used for testing the antibacterial and antifungal activity. Overnight culture of bacterial and fungal strains was done in nutrient agar (HiMedia, Mumbai) at 37±2°C. A loopful of isolated colony of the overnight grown culture was inoculated in 4ml of Peptone water (HiMedia, Mumbai) at 37°C for 2 h. The turbidity of resulting suspension was compared to 0.5 McFarland turbidity standards. The level of turbidity was equivalent to approximately 3.0 × 105 cfu/ml. The Mueller Hinton Agar media (HiMedia, Mumbai) was prepared and poured into Petri dishes. Once the media solidifies it was then inoculated with microorganism suspended in peptone water.
The filter paper discs were impregnated with the extracts and placed individually on the Mueller-Hinton agar with flamed forceps and gently pressed down to ensure contact with the agar surface.
The discs were placed far enough from each other to avoid both reflection waves and overlapping rings of inhibition. DMSO was used as negative control. The experiment was performed at four different concentrations (50, 100, 200 and 400mg/ml). The Petri dishes were incubated for 24 h at 37±2°C for the bacteria. Sabouraud agar was used for C.albicans and tested by the same method as described above. The Zone of inhibitions produced by sensitive organisms were demarcated by a circular area of clearing around C.esculenta plant extract impregnated discs and were compared with zone of inhibitions of standards (Gentamicin 10μg, Ceftazidime 30μg and Fluconazole 25μg) and control (DMSO). The tests were repeated five times to ensure reliability.
Statistical Analysis: Statistical Analysis of the data was done by using One-way ANOVA with Dunnett’s posthoc test using Graph pad prism software. P value <0.05 was considered statistically significant.
RESULTS: In our study, ethanolic extract of C. esculenta showed antibacterial activity against S. aureus, P. aeruginosa, E.coli, Kleibsiella and antifungal activity against C. albicans in a dose dependant manner.
The results were found to be statistically significant when compared with the standard drugs Gentamicin and Ceftazidime (p<0.05) for antibacterial activity and the standard drug Fluconazole (p<0.05) for antifungal activity. However, the antibacterial and antifungal activity at dose EECE (100mg/ml) does not show significant difference when compared to EECE (200mg/ml). Also, there is no significant difference between dose EECE (200 mg/ml) and EECE (400mg/ml).
TABLE 1: ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY OF ETHANOLIC EXTRACT OF LEAVES OF COLOCASIA ESCULENTA (EECE) BY MEASURING THE ZONE OF INHIBITION IN AGAR DISC DIFFUSION METHOD
Measurement of Zone of inhibition (in mm) | |||||
Staphylococcus aureus | Pseudomonas auruginosa | Escherichia coli | Kleibsiella | Candida albicans | |
DMSO (Control) | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |
EECE (50mg/ml) | 3.3 ± 0.32 a,b | 4.2 ± 1.1a,b | 4.6± 0.67a,b | 3.5 ± 0.76a,b | 5.7 ± 2.1a,b |
EECE(100 mg/ml) | 8.24± 0.66 a,b,c | 9.32 ± 0.43a,b,c | 9.21±1.4a,b,c | 8.21± 1.5a,b,c | 6.3±0.78a,b,c |
EECE(200 mg/ml) | 11 ± 1.21a,b,d | 14.6± 1.54a,b,d | 16.2±1.2a,b,d | 13.8±0.76a,b,d | 11.54±1.2a,b,d |
EECE(400 mg/ml) | 14.3 ± 1.45a,b | 17. 4 ± 0.57a,b | 17.1±0.62a,b | 16.4± 0.43a,b | 16.2 ± 0.54a,b |
Gentamicin (10 μg) | 25.06 ± 0.25a | 26.12 ± 0.34a | 28.04 ± 1.1a | 28.32± 0.43a | …………. |
Ceftazidime (30 μg) | 25.67 ± 0.78a | 25.07 ± 1.2a | 25.65±0.65a | 24.23± 0.12a | ………….. |
Fluconazole (25 μg) | ……….. | ………… | …………. | …………. | 28.42±0.65a |
Values are expressed as Mean ± SEM (n=5); One Way ANOVA followed by Dunnett’s multiple comparison tests. a- p<0.05 when compared to control, b- p<0.05 when compared to standard, c- p>0.05 when compared to EECE(200 mg/dl), d- p>0.05 when compared to EECE (400mg/dl)
DISCUSSION: In our study, it is seen that ethanolic extract of the leaves of Colocasia esculenta shows antibacterial activity against S. aureus, P.aeruginosa, E.coli and Kleibsiella and antifungal activity against C.albicans. Govindrajan et al showed various solvent extracts of leaves exhibited inhibitory property against S. aureus, Staph. Epidermis, Bacillus cereus, Streptococcus fecalis 14. The World Health Organization estimates that plant extract or their active constituents are used as folk medicine in traditional therapies of 80% of the words population 15. The zone of inhibition with EECE (400mg/ml) was 17. 4 ± 0.57 for P.aeruginosa which correlate with the result obtained in another study Fahmeeda et al who studied the antibacterial activity of Aegle marmelos 16. In a similar study Dhanraj BN. et al , it was seen that various extracts of the leaves of Colocasia esculenta exhibited antibacterial activities against P. aeruginosa, E. coli, Bacillus, Salmonella typhi etc 17. Yang et al. evaluated the antifungal activity of C.esculenta, along with molecular cloning and recombinant gene expression studies 18.
Phytochemical studies demonstrated the presence of beta-carotene, iron, folic acid alkaloids, alkyl-resorcinols, glycosides, phenolics, saponins, sterols, essential oils, resins, numerous sugars and organic acids in Colocasia esculenta 19.
Secondary metabolites such as tannins, terpenoids, alkaloids, flavonoids, glycosides etc, which have been found in vitro to have antimicrobial properties 20, 21. An antifungal compound, 9, 12, 13-(trihydroxy-(E)-10-octadecenoic acid, and two enzymes, lipoxygenase and lipid hydroperoxide-converting enzyme, which are responsible for the production of antifungal lipid peroxides, were detected in taro tubers infected by C.eratocystis fimbriata 4. Medicinal plants possessing such phyto constituents bear high potential for inclusion into the world of antimicrobial drugs.
CONCLUSION: Considering the results obtained in the study, we can assume that the ethanolic leaf extract of Colocasia esculenta Linn. might become a useful component in the treatment of bacterial and fungal diseases. The development of more purified products and the active components responsible for its antibacterial and antifungal property of Colocasia esculenta should be emphasized as well as the inclusion of the herbal medicines in the treatment of various infections should be encouraged. Further well designed studies are necessary to throw light o the various uses of herbal drugs for the benefit of mankind.
ACKNOWLEDGEMENT: We are thankful to Department of Microbiology, Gauhati Medical College, Assam for their help and co-operation during the testing procedure
SOURCE OF FUNDING: Nil
CONFLICT OF INTEREST: Nil
REFERENCES:
- Sharma A: Antibacterial activity of ethanolic extracts of some arid zone plants. Int. J. Of pharm. Tech Res 2011; 3(1):283-6.
- Gayatri D, K. M. Koley, Vadlamudi V.P, Mishra A, Poddar A and Hirpurkar S.D: Antibacterial activity of Moringa Oleifera (drumstick) root bark. Chem. Pharm. Res 2010; 2(6):424-8
- Shah A, Maithilee J, Shah H, Chaudhary N, Shah A: Antimicrobial Effect of Clove Oil (Laung) Extract on Enterococcus faecalis. Adv. Oral Res 2014 ; 5(3):36-8
- Prajapati R, Kalariya M, Umbarkar R, Parmar S, Sheth N: Colocasia esculenta: A potent indigenous plant. Int J Nutr Pharmacol Neurol Dis 2011;1:90-6
- Colocasia esculenta. https://en.wikipedia.org/wiki/ Colocasia_esculenta as accessed on 1st August 2016.
- Chakraborty P, Deb P, Chakraborty S, Chatterjee B and Abraham J: Cytotoxicity and antimicrobial activity of Colocasia esculenta. J. Chem. Pharm. Res 2015; 7(12): 627-35
- Panda S. A study on leaves and fronds consumed as vegetables and salads in west bengal state, India. Int J of Adv in Pharmacy, Biology and Chemistry 2015;4(3):685-97
- Sheth AK: The Herbs of Ayurveda. Ahmedabad: A.K. Sheth Publishers 2005. p. 356
- Deori M: Vascular Hydrophytic Medicinal Plants of Morigaon district, Assam. Int J of Humanities, Arts, Med and Sci 2015;3(4):17-22
- Sahoo K.P., Pawan K. Kasera and Sher Mohammed: Secondary metabolites produced during different seasons in some arid medicinal plants Asian J of Plant Science and Res 2012; 2(6), 650-2.
- Sangtam TL, Jamir NS, Deb CR, Jamir S: A Study on the Medicinal Plants Used by the Sangtam Naga Tribe in Kiphire District, Nagaland, India. Int J of Ayurvedic And Herbal Med 2012; 2(2): 267-75
- Clark WE: Extracta Liquida Pharmaceutical Formulations. In: Le G, editors. The Chemist and Druggist Book. 11th ed. London: Essex Street Strand 1950. p. 183.
- Bauer, A. W., W. M. M. Kirby, J. C. Sherris, and M. Turck: Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol 1966; 36:493-6.
- Govindrajan M.A, Jebanesan D., Reetha R., Asmath T. Pushpanathan, Samidurai K: Antibacterial activity of Acalypha indica, European Rev for Medical and Pharmacological Sci 2008; 12:299-302
- Bhalodia NR, Nariya PB, Shukla VJ: Antibacterial and antifungal activity from flower extracts of Cassia fistula: an ethnomedicinal plant. Int J of Pharm Tech Res 2011; 3(1):160-8
- Fahmeeda B., Jayaprakashreddy G., Shivakrishna and Rajitha K: Wound healing, antimicrobial and anti fungalactivities of ethanolic leaf extract of Aegle marmelos in rats. J of Cell and Tissue Res 2014,14(1): 4173-9
- Dhanraj BN., Kadam MS, Patil KN and Vinayak SM: Phytochemical screening and Antibacterial Activity of Western Region wild leaf Colocasia esculenta. Int Res J of Biological Sci 2013,2(10):18-21
- Yang AH, Yeh KW: Molecular cloning, recombinant gene expression, and antifungal activity of cystatin from taro (Colocasia esculenta Kaosiung no.1). Planta Med 2005; 221:493-501.
- Chandra S, Saklani S, Singh J: Phytochemical Screening of Garhwal Himalaya Wild Edible Tuber Colocasia Esculenta. Int Res J of Pharmacy 2012;3(3):181-6
- Dahanukar S.A., Kulkarni RA., Rege N.N: Pharmacology of Medicinal Plants and Natural Products. Indian J Pharmacology 2000, 32, S81-S118
- Cowan MM: Plant products as antimicrobial agents. Clinical microbiology reviews 1999, 12: 564-82.
How to cite this article:
Dutta S and Aich B: A study of antibacterial and antifungal activity of the leaves of Colocasia esculenta linn. Int J Pharm Sci Res 2017; 8(3): 1184-87.doi: 10.13040/IJPSR.0975-8232.8(3).1184-87.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
25
1184-1187
354
2088
English
IJPSR
Sarmistha Dutta * and Biswajit Aich
Department of Pharmacology, Gauhati Medical College and Hospital, Guwahati, Assam, India.
mistha007@yahoo.co.in
15 August, 2016
11 November, 2016
09 November, 2016
10.13040/IJPSR.0975-8232.8(3).1184-87
01 March, 2017